This guideline provides details on the pathology and clinical features of Mycoplasma genitalium infection and makes recommendations for diagnostic tests, treatment regimens and the health promotion principles needed for the effective management of infection, in people aged 16 years or older attending sexual health services. The guideline is primarily aimed at level 3 sexual health services in the UK, although it could also serve as a reference guide for sexually transmitted infections services at other levels. It is updated from the previous guideline published in 2018.
SoniSHornerPRaymentM, et al.British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS2019; 30(10): 938–950.
2.
SonnenbergPIsonCACliftonS, et al.Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third national survey of sexual attitudes and lifestyles (Natsal-3). Int J Epidemiol2015; 44(6): 1982–1994.
3.
GetmanDJiangAO’DonnellM, et al.Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol2016; 54(9): 2278–2283.
4.
HetemDJKuizenga WesselSBruistenSM, et al.High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in The Netherlands. Int J STD AIDS2021; 32(9): 837–844.
5.
le RouxMCHoosenAA. Quantitative real-time polymerase chain reaction for the diagnosis of Mycoplasma genitalium infection in South African men with and without symptoms of urethritis. Sex Transm Dis2017; 44(1): 17–20.
6.
NapieralaMMunsonEWentenD, et al.Detection of Mycoplasma genitalium from male primary urine specimens: an epidemiologic dichotomy with Trichomonas vaginalis. Diagn Microbiol Infect Dis2015; 82(3): 194–198.
7.
SokollPRMigliavacaCBSiebertU, et al.Prevalence of Mycoplasma genitalium infection among HIV PrEP users: a systematic review and meta-analysis. Sex Transm Infect2023; 99(5): 351–359.
8.
BissessorMTabriziSNBradshawCS, et al.The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men. Clin Microbiol Infect2016; 22(3): 260–265.
9.
SoniSAlexanderSVerlanderN, et al.The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect2010; 86(1): 21–24.
10.
EdlundMBlaxhultABrattG. The spread of Mycoplasma genitalium among men who have sex with men. Int J STD AIDS2012; 23(6): 455–456.
11.
BradleyIVarmaRKnightV, et al.Prevalence of rectal Mycoplasma genitalium and macrolide resistance in men who have sex with men attending Sydney Sexual Health Centre. Sex Health2020; 17(2): 114–120.
12.
BradshawCSFairleyCKListerNA, et al.Mycoplasma genitalium in men who have sex with men at male-only saunas. Sex Transm Infect2009; 85(6): 432–435.
13.
DeguchiTYasudaMYokoiS, et al.Failure to detect Mycoplasma genitalium in the pharynges of female sex workers in Japan. J Infect Chemother2009; 15(6): 410–413.
HarrisonSAOlsonKMRatliffAE, et al.Mycoplasma genitalium coinfection in women with Chlamydia trachomatis infection. Sex Transm Dis2019; 46(10): e101–e104.
16.
RichardsonDLewisDAJeoffreysNJ, et al.Mycoplasma genitalium coinfection in men with symptomatic gonococcal urethritis. Sex Transm Infect2021; 97(5): 363–367.
17.
VandepitteJWeissHAKyakuwaN, et al.Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda. Sex Transm Dis2013; 40(5): 422–427.
18.
MavedzengeSNVan Der PolBWeissHA, et al.The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS2012; 26(5): 617–624.
19.
GoldenMRWorkowskiKABolanG. Developing a public health response to Mycoplasma genitalium. J Infect Dis2017; 216(suppl_2): S420–S426.
20.
OakeshottPAghaizuAHayP, et al.Is Mycoplasma genitalium in women the “New Chlamydia?” A community-based prospective cohort study. Clin Infect Dis2010; 51(10): 1160–1166.
21.
BalkusJEManhartLEJensenJS, et al.Mycoplasma genitalium infection in Kenyan and US women. Sex Transm Dis2018; 45(8): 514–521.
22.
BradshawCSJensenJSWaitesKB. New horizons in Mycoplasma genitalium treatment. J Infect Dis2017; 216(suppl_2): S412–S419.
23.
HornerPIngleSMGarrettF, et al.Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis. Sex Transm Infect2018; 94(1): 14–20.
24.
BradshawCSHornerPJJensenJS, et al.Syndromic management of STIs and the threat of untreatable Mycoplasma genitalium. Lancet Infect Dis2018; 18(3): 251–252.
25.
Taylor-RobinsonDJensenJS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev2011; 24(3): 498–514.
26.
WikstromAJensenJS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect2006; 82(4): 276–279.
27.
FalkLFredlundHJensenJS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex Transm Infect2004; 80(4): 289–293.
28.
JensenJSOrsumRDohnB, et al.Mycoplasma genitalium: a cause of male urethritis?Genitourin Med1993; 69(4): 265–269.
29.
AnagriusCLoréBJensenJS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One2013; 8(4): e61481.
30.
WetmoreCMManhartLELowensMS, et al.Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study. Sex Transm Dis2011; 38(3): 180–186.
31.
ItoSHanaokaNShimutaK, et al.Male non-gonococcal urethritis: from microbiological etiologies to demographic and clinical features. Int J Urol2016; 23(4): 325–331.
32.
ManhartLECritchlowCWHolmesKK, et al.Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis2003; 187(4): 650–657.
33.
LisRRowhani-RahbarAManhartLE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis2015; 61(3): 418–426.
34.
LatimerRLVodstrcilLAPlummerEL, et al.The clinical indications for testing women for Mycoplasma genitalium. Sex Transm Infect2022; 98(4): 277–285.
35.
BainbridgeEDSogeOOGrabowC, et al.163. High prevalence of urogenital and rectal Mycoplasma genitalium in U.S. MSM with a history of STIs in the last year. Open Forum Infect Dis2021; 8: S98–S99.
36.
BarbeeLGoldenMSogeO, et al.Rectal and pharyngeal M. Genitalium among men who have sex with men (MSM): results from a longitudinal cohort study. Sex Transm Infect2019; 95: A258.
37.
LatimerRLShillingHSVodstrcilLA, et al.Prevalence of Mycoplasma genitalium by anatomical site in men who have sex with men: a systematic review and meta-analysis. Sex Transm Infect2020; 96(8): 563–570.
38.
FoschiCGaspariVSgubbiP, et al.Sexually transmitted rectal infections in a cohort of ‘men having sex with men’. J Med Microbiol2018; 67(8): 1050–1057.
39.
OngJJRuanLLimAG, et al.Impact of screening on the prevalence and incidence of Mycoplasma genitalium and its macrolide resistance in men who have sex with men living in Australia: a mathematical model. EClinicalMedicine2021; 33: 100779.
40.
ChowEPFLeeDBondS, et al.Nonclassical pathogens as causative agents of proctitis in men who have sex with men. Open Forum Infect Dis2021; 8(7): ofab137.
SimmsIEastickKMallinsonH, et al.Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm Infect2003; 79(2): 154–156.
43.
DeanGWhethamJSoniS, et al.O031 pelvic inflammatory disease (PID), Mycoplasma genitalium and macrolide resistance in England. Sex Transm Infect2016; 92(Suppl 1): A12.
44.
LewisJHornerPJWhitePJ. Incidence of pelvic inflammatory disease associated with Mycoplasma genitalium infection: evidence synthesis of cohort study data. Clin Infect Dis2020; 71(10): 2719–2722.
45.
CohenCRManhartLEBukusiEA, et al.Association between Mycoplasma genitalium and acute endometritis. Lancet2002; 359(9308): 765–766.
46.
TaylorBDZhengXO'ConnellCM, et al.Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell response against Chlamydia (TRAC) study. Sex Transm Infect2018; 94(6): 414–420.
47.
BaczynskaAFunchPFedderJ, et al.Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis-in vitro organ culture study. Hum Reprod2007; 22(4): 968–979.
48.
WiesenfeldHCManhartLE. Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen. J Infect Dis2017; 216(suppl_2): S389–S395.
49.
ItoSTsuchiyaTYasudaM, et al.Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years-of-age with acute epididymitis. Int J Urol2012; 19(3): 234–238.
50.
Fernandez VecillaDAragon DiezJNieto TobosoMC, et al.Could Mycoplasma genitalium be involved in chronic granulomatous orchiepididymits? Case report and literature review. Rev Esp Quimioter2023; 36(1): 103–106.
51.
PapešDPasiniMJerončićA, et al.Detection of sexually transmitted pathogens in patients with chronic prostatitis/chronic pelvic pain: a prospective clinical study. Int J STD AIDS2017; 28(6): 613–615.
52.
RossottiRTraviGBanaNB, et al.A case of chronic bacterial prostatitis due to Mycoplasma genitalium. Sex Transm Infect2023; 99(8): 571–573.
53.
Taylor-RobinsonDGilroyCBHorowitzS, et al.Mycoplasma genitalium in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis1994; 13(12): 1066–1069.
54.
SimosPStewartAG. Sexually acquired reactive arthritis secondary to macrolide-resistant Mycoplasma genitalium urethritis. Intern Med J2022; 52(2): 332–333.
55.
FrenzerCEgli-GanyDVallelyLM, et al.Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta-analysis. Sex Transm Infect2022; 98(3): 222–227.
Le RoyCLe HenIClercM, et al.The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. J Microbiol Methods2012; 89(3): 193–197.
59.
TabriziSNTanLYWalkerS, et al.Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexZyme and PlexPrime technology. PLoS One2016; 11(6): e0156740.
60.
ShipitsynaEZolotoverkhayaEDohnB, et al.First evaluation of polymerase chain reaction assays used for diagnosis of Mycoplasma genitalium in Russia. J Eur Acad Dermatol Venereol2009; 23(10): 1164–1172.
61.
JensenJSBjorneliusEDohnB, et al.Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis2004; 31(8): 499–507.
62.
GaydosCAManhartLETaylorSN, et al.Molecular testing for Mycoplasma genitalium in the United States: results from the AMES prospective multicenter clinical study. J Clin Microbiol. 2019; 57(11): 57.
63.
DizeLBarnesPJrBarnesM, et al.Performance of self-collected penile-meatal swabs compared to clinician-collected urethral swabs for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium by nucleic acid amplification assays. Diagn Microbiol Infect Dis2016; 86(2): 131–135.
64.
JayaZNMapangaWDlangalalaT, et al.Accuracy of self-collected versus healthcare worker collected specimens for diagnosing sexually transmitted infections in females: an updated systematic review and meta-analysis. Sci Rep2024; 14(1): 10496.
65.
MobleyVLHobbsMMLauK, et al.Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors. Sex Transm Dis2012; 39(9): 706–709.
66.
LillisRANsuamiMJMyersL, et al.Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol2011; 49(5): 1990–1992.
67.
Van Der PolBWaitesKBXiaoL, et al.Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG Test. J Clin Microbiol2020May 26;58(6):e02124-19.
LauABradshawCSLewisD, et al.The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis2015; 61(9): 1389–1399.
70.
ChuaT-PVodstrcilLAMurrayGL, et al.Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated global systematic review and meta-analysis. SSRN. 2024. DOI: 10.2139/ssrn.4764790.
DurukanDReadTRHMurrayG, et al.Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5 g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability. Clin Infect Dis2020; 71(6): 1461–1468.
73.
ReadTRHFairleyCKMurrayGL, et al.Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium Infections: a prospective evaluation. Clin Infect Dis2019; 68(4): 554–560.
74.
GesinkDCMulvadGMontgomery-AndersenR, et al.Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int J Circumpolar Health2012; 71: 1–8.
75.
ManhartLEJensenJSBradshawCS, et al.Efficacy of antimicrobial therapy for Mycoplasma genitalium infections. Clin Infect Dis2015; 61(Suppl 8): S802–S817.
76.
MurrayGPlummerELBodihabaduK, et al.GyrA mutations in Mycoplasma genitalium contribute to moxifloxacin failure - a new target for resistance-guided therapy. Sex Transm Dis2024; 51(1): S18.
LiYLeWJLiS, et al.Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. Int J STD AIDS2017; 28(11): 1106–1114.
79.
ClarkeEJVodstrcilLAPlummerEL, et al.Efficacy of minocycline for the treatment of Mycoplasma genitalium. Open Forum Infect Dis2023; 10(8): ofad427.
80.
HamasunaRJensenJSOsadaY. Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrob Agents Chemother2009; 53(11): 4938–4939.
81.
ReadTRHJensenJSFairleyCK, et al.Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection. Emerg Infect Dis2018; 24(2): 328–335.
82.
HtaikKVodstrcilLAPlummerEL, et al.Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium. J Antimicrob Chemother. 2025; 80: 1878–1884.
83.
PerinJColemanJSRondaJ, et al.Maternal and fetal outcomes in an observational cohort of women with Mycoplasma genitalium infections. Sex Transm Dis2021; 48(12): 991–996.
84.
Bar-OzBWeber-SchoendorferCBerlinM, et al.The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study. Drug Saf2012; 35(7): 589–598.
85.
SarkarMWoodlandCKorenG, et al.Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth2006; 6: 18.
86.
CooperWOHernandez-DiazSArbogastPG, et al.Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol2009; 23(1): 18–28.
KelseyJJMoserLRJenningsJC, et al.Presence of azithromycin breast milk concentrations: a case report. Am J Obstet Gynecol1994; 170(5 Pt 1): 1375–1376.
91.
LundMPasternakBDavidsenRB, et al.Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ2014; 348: g1908.
92.
Doxycycline In: Joint Formulary Committee. British national formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain. Available from: https://bnf.nice.org.uk/drugs/doxycycline/
93.
CompendiumEM. Doxycycline 100mg capsules- summary of product characteristics (SmPC). UK: Datapharm, 2021. [cited 2025 April 3]. Available from: https://www.medicines.org.uk/emc/product/13082/smpc (accessed 3 April 2025).
KongFYSHornerPUnemoM, et al.Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review. J Antimicrob Chemother2019; 74(5): 1157–1166.
96.
ItoSShimadaYYamaguchiY, et al.Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex Transm Infect2011; 87(5): 412–414.
97.
ManhartLEGillespieCWLowensMS, et al.Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis2013; 56(7): 934–942.
98.
FalkLEngerMJensenJS. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. J Antimicrob Chemother2015; 70(11): 3134–3140.
99.
SlifirskiJBVodstrcilLAFairleyCK, et al.Mycoplasma genitalium Infection in adults reporting sexual contact with infected partners, Australia, 2008-2016. Emerg Infect Dis2017; 23(11): 1826–1833.
100.
CinaMBaumannLEgli-GanyD, et al.Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis. Sex Transm Infect2019; 95(5): 328–335.
101.
McCleanHRadcliffeKSullivanA, et al.2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS2013; 24(4): 253–261.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
